#AIEye
#Podcast 565: #Stocks discussed: (OTCPINK: $GTCH) (NasdaqGS: $SRGA);
#artificialintelligence
GBT
Starts Research on AI-Empowered Wireless Patient Monitoring System, and
Surgalign Collaborating with Inteneural Networks
Global
#AI in #Healthcare Diagnosis Market to Reach $66.81B by 2027
Point Roberts WA, Vancouver BC – June 7, 2021 – Investorideas.com (www.investorideas.com), a global investor news source covering
Artificial Intelligence (AI) brings you today’s edition of The
AI Eye- watching stock news, deal tracker and advancements in
artificial intelligence – featuring technology company GBT
Technologies Inc. (OTCPINK:GTCH).
Listen
to today’s podcast:
https://www.investorideas.com/Audio/Podcasts/2021/060721-AI-Eye.mp3
Read
this in full at https://www.investorideas.com/news/2021/artificial-intelligence/06071GTCH-SRGA.asp
Today’s
Column- The
AI Eye- Watching stock news, deal tracker and advancements
in artificial intelligence
Stocks
discussed: (OTCPINK:GTCH) (NasdaqGS:SRGA)
GBT Technologies Inc. (OTC PINK:GTCH) has announced that it has commenced research on
the development of an AI-empowered, wireless patient monitoring system with the
internal code name Apollo. GBT’s CTO
Danny Rittman explained:
"We
are researching to develop an out-of-the-box monitoring device for patients and
the elderly that is radio-based and AI-empowered. It is our goal to particularly
serve people that do not like to wear monitoring devices and yet need to be
monitored at their home or at a facility. The Apollo device will be using RF
signals to transmit in specific frequencies and analyze the reflection data. It
is our goal to use a deep learning analysis to determine if the data belong to
a human or objects and will calculate heart rate, breathing, and movement. It
is our goal that a person would not need to wear any electronic device and the
system will be able to detect his/her daily activities. The goal of the system
will be to detect, in real time, irregularities like a fall, low breathing or
an irregular heartbeat and to alert emergency response. Since the system will
be working via radio waves, it will be able to cover an entire home
environment."
Medical tech firm Surgalign Holdings, Inc. (NasdaqGS:SRGA) has entered into a strategic collaboration
agreement with Inteneural Networks Inc., the latter of which is described as “a
developer of innovative artificial intelligence (AI) based applications focused
on fully autonomous analytics of central nervous system imaging.” The
collaboration will see Surgalign “gain access to Inteneural’s proprietary
technology for evaluation of future integration within the Surgalign digital
surgery portfolio.” Surgalign’s CEO Terry Rich said:
“While
our initial focus is the application of digital surgery in spine procedures, we
have a much more expansive vision for what we believe is possible with emerging
technologies. New developments in the application of AI in neurosurgery and
medical imaging make it an attractive space to further expand. Inteneural has
developed machine learning-based analytics and fully autonomous brain anatomy
segmentation capabilities that would be incredibly powerful when combined with
neurosurgery. The agreement between Surgalign and Inteneural sets the
foundation for potentially enhanced research and development efficiencies,
expansion of the addressable markets, and acceleration of the technological
progress in the digital surgery space generally.”
Global
AI in Healthcare Diagnosis Market to Reach $66.81B by 2027
A report published by Research and Markets finds that the global AI
in Healthcare Diagnosis market will grow from $3.63 billion in 2019 to $66.81
billion by 2027 with a compound annual growth rate (CAGR) of 43.8 percent in
the forecast period. The following excerpt from the report’s description outlines
the influence of startups on the market’s growth:
Artificial
Intelligence in healthcare is one of the most significant technological
advancements in medicine so far. The involvement of multiple startups in the
development of AI-driven imaging and diagnostic solutions is the major factor
contributing to the growth of the market. China, the US, and the UK are
emerging as popular hubs for healthcare innovations. Additionally, the British
government has announced the establishment of a National Artificial
Intelligence Lab that would collaborate with the country’s universities and
technology companies to conduct research on cancer, dementia, and heart
diseases. The UK-based startups have received benefits from the government’s
robust library of patient data, as British citizens share their anonymous
healthcare data with the British National Health Service. As a result, the
number of artificial intelligence startups in the healthcare sector has
significantly grown in the past few years, and the trend is expected to be the
same in the coming years.
Sam Mowers, Investorideas.com
Read and
hear other editions of the AI Eye
For a list of
artificial intelligence stocks on Investorideas.com visit
here
Investors can
trade these stocks and other ideas on
our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.
About
Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com
publishes breaking stock news, third party stock research, guest posts and
original articles and podcasts in leading stock sectors. Learn about investing in stocks and get
investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy, gaming and more. Investor Idea’s original branded content
includes podcasts and columns : Crypto Corner , Play
by Play sports and stock
news , Investor Ideas Potcasts
Cannabis News and Stocks on the Move podcast ,
Cleantech
and Climate Change , Exploring
Mining , Betting
on Gaming Stocks Podcast and the AI
Eye
Podcast.
The Investorideas.com podcasts are also available
on iTunes ( Apple Podcasts) , Audible ,
Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Play Music and
most audio platforms available.
Visit the Podcast page at
Investorideas.com:
https://www.investorideas.com/Audio/
Disclaimer/Disclosure: Investorideas.com is a digital publisher of
third party sourced news, articles and equity research as well as creates
original content, including video, interviews and articles. Original content
created by investorideas is protected by copyright laws other than syndication
rights. Our site does not make recommendations for purchases or sale of stocks,
services or products. Nothing on our sites should be construed as an offer or
solicitation to buy or sell products or securities. All investing involves risk
and possible losses. This site is currently compensated for news publication
and distribution, social media and marketing, content creation and more.
Disclosure is posted for each compensated news release, content published
/created if required but otherwise the news was not compensated for and was
published for the sole interest of our readers and followers. Contact
management and IR of each company directly regarding specific questions. More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing
your news release and our other news services on the Investorideas.com
newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com Global investors
must adhere to regulations of each country. Please read Investorideas.com
privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Disclosure: GTCH
is a paid monthly featured ai stock
The AI Eye- Watching stock news, deal tracker and
advancements in artificial intelligence is an original content brand of
Investorideas.com
Follow us on
Twitter https://twitter.com/Investorideas
Follow us on
Facebook https://www.facebook.com/Investorideas
Follow us on
YouTube https://www.youtube.com/c/Investorideas
Download our Mobile
App for iPhone and
Android
Join our Investor
Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665 0411
Get more Technology
stock investor ideas - news, articles,
podcasts and stock directories
